Financial Daily from THE HINDU group of publications
Wednesday, May 04, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Info-Tech - Alliances & Joint Ventures


HCL, IIT Delhi join hands for drug research

Our Bureau

New Delhi , May 3

HCL Technologies has signed a memorandum of understanding with Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at IIT-Delhi on high-end projects in the area of drug discovery and development, including genomics and proteomics projects.

"HCL plans to team up with premier bioinformatics research institutions across the world to build fundamental capabilities and grow talent pool in India in this domain," an HCL release said here.

The Life Sciences practice at HCL provides tested solutions in areas such as pharmacogenomics, RFID-based drug counterfeit solutions, medical devices and diagnostics, contract manufacturing, and hospital information systems.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
VSNL gets US regulatory nods for Tyco buy


BSNL plans undersea cable to Singapore
TRAI to propose 30 Mhz additional spectrum for 3G services
R.R. Industries tech park inaugurated; announces Rs 60-cr new project
No change in duty on laptops: MAIT
Maran to pitch for Intel chip plant
`IT sector earns Rs 1,00,000 cr'
Symbol opens Bangalore centre
Infosys adopts SEC format
Sify tool for TotalFinaElf
Oracle to acquire PeopleSoft centres in Bangalore
Tribunal quashes TRAI order on direct connectivity
HCL, IIT Delhi join hands for drug research
VeriSign opens India centre
TDSAT upholds DoT's entry fee for VPN service
Singapore IT fair in June
NIIT's national aptitude test


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line